DNMT cooperativity - The developing links between methylation, chromatin structure and cancer

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Controversy has reigned for some time over the biological connection between DNA methylation and cancer. For this reason, the methylation mechanism responsible for increased cancer risk has received greater attention in recent years. Tumor suppressor genes are often hypermethylated resulting in gene silencing. Although some have questioned this interpretation of the link between methylation and cancer, it appears that both hypermethylation and hypomethylation events can create epigenetic changes that can contribute to cancer development. Recent studies have shown that the methyltransferases DNMT1 and DNMT3b cooperatively maintain DNA methylation and gene silencing in human cancer cells. Disruption of the human DNMT3b only slightly reduces the overall global DNA methylation; however, demethylation was markedly potentiated when both DNMT1 and DNMT3b were simultaneously deleted. The results to these experiments provide compelling evidence towards a role for DNA methylation in cancer. This review discusses the current understanding of cancer-epigenetic information and highlights recent studies that connect the methylation machinery and chromatin remodelling with cancer susceptibility.

Original languageEnglish
Pages (from-to)1071-1084
Number of pages14
JournalBioEssays
Volume25
Issue number11
DOIs
Publication statusPublished - 1 Nov 2003

Cite this

@article{45b36248f4d04a80ab89e6f52b6a32fb,
title = "DNMT cooperativity - The developing links between methylation, chromatin structure and cancer",
abstract = "Controversy has reigned for some time over the biological connection between DNA methylation and cancer. For this reason, the methylation mechanism responsible for increased cancer risk has received greater attention in recent years. Tumor suppressor genes are often hypermethylated resulting in gene silencing. Although some have questioned this interpretation of the link between methylation and cancer, it appears that both hypermethylation and hypomethylation events can create epigenetic changes that can contribute to cancer development. Recent studies have shown that the methyltransferases DNMT1 and DNMT3b cooperatively maintain DNA methylation and gene silencing in human cancer cells. Disruption of the human DNMT3b only slightly reduces the overall global DNA methylation; however, demethylation was markedly potentiated when both DNMT1 and DNMT3b were simultaneously deleted. The results to these experiments provide compelling evidence towards a role for DNA methylation in cancer. This review discusses the current understanding of cancer-epigenetic information and highlights recent studies that connect the methylation machinery and chromatin remodelling with cancer susceptibility.",
author = "Assam El-Osta",
year = "2003",
month = "11",
day = "1",
doi = "10.1002/bies.10345",
language = "English",
volume = "25",
pages = "1071--1084",
journal = "BioEssays",
issn = "0265-9247",
publisher = "Wiley-VCH Verlag GmbH & Co. KGaA",
number = "11",

}

DNMT cooperativity - The developing links between methylation, chromatin structure and cancer. / El-Osta, Assam.

In: BioEssays, Vol. 25, No. 11, 01.11.2003, p. 1071-1084.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - DNMT cooperativity - The developing links between methylation, chromatin structure and cancer

AU - El-Osta, Assam

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Controversy has reigned for some time over the biological connection between DNA methylation and cancer. For this reason, the methylation mechanism responsible for increased cancer risk has received greater attention in recent years. Tumor suppressor genes are often hypermethylated resulting in gene silencing. Although some have questioned this interpretation of the link between methylation and cancer, it appears that both hypermethylation and hypomethylation events can create epigenetic changes that can contribute to cancer development. Recent studies have shown that the methyltransferases DNMT1 and DNMT3b cooperatively maintain DNA methylation and gene silencing in human cancer cells. Disruption of the human DNMT3b only slightly reduces the overall global DNA methylation; however, demethylation was markedly potentiated when both DNMT1 and DNMT3b were simultaneously deleted. The results to these experiments provide compelling evidence towards a role for DNA methylation in cancer. This review discusses the current understanding of cancer-epigenetic information and highlights recent studies that connect the methylation machinery and chromatin remodelling with cancer susceptibility.

AB - Controversy has reigned for some time over the biological connection between DNA methylation and cancer. For this reason, the methylation mechanism responsible for increased cancer risk has received greater attention in recent years. Tumor suppressor genes are often hypermethylated resulting in gene silencing. Although some have questioned this interpretation of the link between methylation and cancer, it appears that both hypermethylation and hypomethylation events can create epigenetic changes that can contribute to cancer development. Recent studies have shown that the methyltransferases DNMT1 and DNMT3b cooperatively maintain DNA methylation and gene silencing in human cancer cells. Disruption of the human DNMT3b only slightly reduces the overall global DNA methylation; however, demethylation was markedly potentiated when both DNMT1 and DNMT3b were simultaneously deleted. The results to these experiments provide compelling evidence towards a role for DNA methylation in cancer. This review discusses the current understanding of cancer-epigenetic information and highlights recent studies that connect the methylation machinery and chromatin remodelling with cancer susceptibility.

UR - http://www.scopus.com/inward/record.url?scp=0242551379&partnerID=8YFLogxK

U2 - 10.1002/bies.10345

DO - 10.1002/bies.10345

M3 - Review Article

VL - 25

SP - 1071

EP - 1084

JO - BioEssays

JF - BioEssays

SN - 0265-9247

IS - 11

ER -